Resultados da pesquisa - V.‐P. Harjola

  • A mostrar 1 - 6 resultados de 6
Refinar resultados
  1. 1
    Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP

    Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Por Johan Lassus, V.‐P. Harjola, Reijo Sund, Krista Siirilä‐Waris, J. Melin, Keijo Peuhkurinen, Kari Pulkki, Markku S. Nieminen

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II

    Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II Por Michel Komajda, Olivier Hanon, M. Hochadel, José López‐Sendón, F Follath, Piotr Ponikowski, V.‐P. Harjola, H. Drexler, Kenneth Dickstein, Luigi Tavazzi, Markku S. Nieminen

    Publicado em 2008
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population

    EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Por Markku S. Nieminen, D L Brutsaert, Kenneth Dickstein, H. Drexler, Ferenc Folláth, V.‐P. Harjola, M. Hochadel, M Komajda, Johan Lassus, José López‐Sendón, Piotr Ponikowski, Luigi Tavazzi

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application

    Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application Por Stefaan Bouchez, Francesco Fedele, George Giannakoulas, Finn Gustafsson, V.‐P. Harjola, Kristjan Karason, Matti Kivikko, Dirk von Lewinski, Fabrizio Oliva, Zoltán Papp, John Parissis, Piero Pollesello, Gerhard Pölzl, Carsten Tschöpe

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  5. 5
    High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin

    High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin Por Ziad Hijazi, Lars Wallentin, Agneta Siegbahn, Ulrika Andersson, John H. Alexander, Dan Atar, Bernard J. Gersh, Michael G. Hanna, V.‐P. Harjola, John D. Horowitz, Steen Husted, Elaine M. Hylek, Renato D. Lópes, John J.V. McMurray, Christopher B. Granger

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

    Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation Por Greg Flaker, Renato D. Lópes, Sana M. Al‐Khatib, Antonio G. Hermosillo, Stefan H. Hohnloser, Brian Tinga, Jun Zhu, Puneet Mohan, David García, Jozef Bartúnek, Dragoş Vinereanu, Steen Husted, V.‐P. Harjola, Mårten Rosenqvist, John H. Alexander, Christopher B. Granger

    Publicado em 2013
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: